Kursexplosion bei Predictive Oncology
Seite 1 von 1 Neuester Beitrag: 17.04.23 09:53 | ||||
Eröffnet am: | 05.02.20 19:32 | von: moneywork4. | Anzahl Beiträge: | 24 |
Neuester Beitrag: | 17.04.23 09:53 | von: axolot | Leser gesamt: | 7.899 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
https://www.globenewswire.com/news-release/2020/...rs-in-the-Lab.html
http://predictive-oncology.com/tumorgenesis/
Allerdings hierzulande kein Handel nach 20 Uhr (Stuttgart und Tradegate).
Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Cancer Patients.
Quelle:
https://www.globenewswire.com/news-release/2020/...s-Distributor.html
Bin auf den weiteren Verlauf gespannt. Die Entwicklung (Unternehmen sowie Kurs) sieht sehr gut aus. Ich denke in diesem Umfeld steckt noch viel Potential und das Unternehmen (gibt's Mitbewerber - falls ja, welche?) kann sich in dieser Nische weiterhin gut positionieren. Nachbörslich ging's in den US gestern gleich mal über 20% rauf.
Die Darstellung des CEO stimmt mich sehr zuversichtlich, dass der Boden nun erreicht ist und bald eine Trendwende einkehrt.
"EAGAN, Minn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, is pleased to release the CEOs letter to the shareholders.
To our valued shareholders,
I know you have watched our stock price decline steadily over the past few weeks. I am writing to assure you that there is a lot of encouraging progress to report in other words, our company is not in the condition that the stock price might indicate. I want to take this opportunity to review where Predictive Oncology stands as of today.
Our cash burn is stable and trending downward. Our revenues are stable and trending upward. Our available cash is adequate for operations and we have the ability to utilize our equity line of credit, which has a remaining amount of over $10 million.
The best news is in the operational progress in our various divisions. Starting with Skyline Medical, this division is self-supporting from a cash standpoint. Sales of disposables used on previously sold machines more than cover the operating expenses of this division, and we continue to sell new machines on a regular basis, adding to future disposables revenues.
..."
Quelle, 6.10.2020
https://finance.yahoo.com/news/...-letter-shareholders-123000679.html
Quelle, 12.11.2020:
https://www.qualitystocks.com/...ed-at-convergence-of-ai-cancer-care/
...The National Cancer Institute (NCI) in the United States has separately revealed that it is increasingly looking to invest in supporting research and developing infrastructure centered around the usage of AI in developing oncological treatments (https://ibn.fm/BFD5m). This is a niche where Predictive Oncology is increasingly building a dominant presence. In addition, the White House has announced $2 billion funding for public and private sector AI hubs designed to drive key advances in AI as well as other computational technologies (https://ibn.fm/kcgSH)....
Vielleicht bekommt ja POAI auch einen Teil der 2 Mrd. USD Subventionen ab? Ich kann mir vorstellen, dass es wie anderen Sektoren auch im AI-Umfeld zu einem Biden-Boost kommen wird.
Nur 20 Millionen Marketcap
Und:
"Predictive Oncology Reports That Its Wholly Owned Subsidiary,
TumorGenesis, Has Sold Media to Two Top Research Medical Centers"
https://money.tmx.com/en/quote/POAI:US/news/...search_Medical_Centers
Mehr Infos zu Predictive Oncology:
https://predictive-oncology.com/
Wer einstiegen will, sollte vielleicht noch etwas warten.
alles nur meine Meinung, keine Kaufempfehlung und keine Verkaufempfehlung